ema prac semaglutide naion label update 2025 Novo Nordisk's obesity-drug business has exploded in just a few years. Between 2021 and 2025, the company's sales in this segment jumped roughly tenfold: from $1.3 billion to $12.4 billion, driven largely Meeting highlights from the Pharmacovigilance
Pay in 4 interest-free payments of $6.12 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5






















